Ah-Rong Nam

415 total citations
15 papers, 326 citations indexed

About

Ah-Rong Nam is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Ah-Rong Nam has authored 15 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Ah-Rong Nam's work include Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Ah-Rong Nam is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Ah-Rong Nam collaborates with scholars based in South Korea, United States and Puerto Rico. Ah-Rong Nam's co-authors include Ju-Hee Bang, Do‐Youn Oh, Yung‐Jue Bang, Ji Eun Park, Mei Hua Jin, Kyung-Hun Lee, Tae‐Yong Kim, Seock‐Ah Im, Mei Jin and Sae‐Won Han and has published in prestigious journals such as Scientific Reports, British Journal of Cancer and Cancer Letters.

In The Last Decade

Ah-Rong Nam

15 papers receiving 324 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Ah-Rong Nam	240	124	91	67	63	15	326
María San Román	182 0.8×	130 1.0×	98 1.1×	41 0.6×	42 0.7×	16	343
James D. Peyton	200 0.8×	175 1.4×	145 1.6×	61 0.9×	26 0.4×	27	363
Xianjing Chu	201 0.8×	127 1.0×	100 1.1×	21 0.3×	87 1.4×	12	399
María González Cao	207 0.9×	144 1.2×	107 1.2×	29 0.4×	79 1.3×	38	336
Maria Mihaela Mina	168 0.7×	184 1.5×	155 1.7×	41 0.6×	66 1.0×	13	363
Shaochuan Liu	237 1.0×	106 0.9×	89 1.0×	23 0.3×	121 1.9×	15	362
Ciro Longobardi	306 1.3×	133 1.1×	276 3.0×	104 1.6×	38 0.6×	14	514
Ling Dai	238 1.0×	105 0.8×	136 1.5×	25 0.4×	53 0.8×	28	347
Yu Kataoka	176 0.7×	213 1.7×	99 1.1×	24 0.4×	43 0.7×	10	378
Sonia Garofalo	189 0.8×	145 1.2×	126 1.4×	20 0.3×	74 1.2×	7	364

Countries citing papers authored by Ah-Rong Nam

Since Specialization

Citations

This map shows the geographic impact of Ah-Rong Nam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ah-Rong Nam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ah-Rong Nam more than expected).

Fields of papers citing papers by Ah-Rong Nam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ah-Rong Nam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ah-Rong Nam. The network helps show where Ah-Rong Nam may publish in the future.

Co-authorship network of co-authors of Ah-Rong Nam

This figure shows the co-authorship network connecting the top 25 collaborators of Ah-Rong Nam. A scholar is included among the top collaborators of Ah-Rong Nam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ah-Rong Nam. Ah-Rong Nam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Nam, Ah-Rong, et al.. (2021). WEE1 inhibition reverses trastuzumab resistance in HER2-positive cancers. Gastric Cancer. 24(5). 1003–1020. 25 indexed citations

Nam, Ah-Rong, et al.. (2021). ATR inhibition amplifies antitumor effects of olaparib in biliary tract cancer. Cancer Letters. 516. 38–47. 18 indexed citations

Park, Woo Chan, Ju-Hee Bang, Ah-Rong Nam, et al.. (2020). Prognostic Value of Serum Soluble Programmed Death-Ligand 1 and Dynamics During Chemotherapy in Advanced Gastric Cancer Patients. Cancer Research and Treatment. 53(1). 199–206. 12 indexed citations

Park, Hyunkyung, Ju-Hee Bang, Ah-Rong Nam, et al.. (2019). Prognostic implications of soluble programmed death-ligand 1 and its dynamics during chemotherapy in unresectable pancreatic cancer. Scientific Reports. 9(1). 11131–11131. 24 indexed citations

Jin, Mei, Ah-Rong Nam, Ji Eun Park, et al.. (2019). Therapeutic Co-targeting of WEE1 and ATM Downregulates PD-L1 Expression in Pancreatic Cancer. Cancer Research and Treatment. 52(1). 149–166. 30 indexed citations

Kim, Jin Won, Kyung-Hun Lee, Ji‐Won Kim, et al.. (2019). Enhanced antitumor effect of binimetinib in combination with capecitabine for biliary tract cancer patients with mutations in the RAS/RAF/MEK/ERK pathway: phase Ib study. British Journal of Cancer. 121(4). 332–339. 25 indexed citations

Park, Ji Eun, Mei Jin, Ah-Rong Nam, et al.. (2019). GC1118, a novel anti-EGFR antibody, has potent KRAS mutation-independent antitumor activity compared with cetuximab in gastric cancer. Gastric Cancer. 22(5). 932–940. 13 indexed citations

Ha, Hyerim, Ju-Hee Bang, Ah-Rong Nam, et al.. (2018). Dynamics of Soluble Programmed Death-Ligand 1 (sPDL1) during Chemotherapy and Its Prognostic Implications in Cancer Patients: Biomarker Development in Immuno-oncology. Cancer Research and Treatment. 51(2). 832–840. 14 indexed citations

Nam, Ah-Rong, Ji‐Won Kim, Ji Eun Park, et al.. (2018). Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer. Cancer Research and Treatment. 51(3). 886–900. 5 indexed citations

10.

Nam, Ah-Rong, Mei Hua Jin, Ji Eun Park, et al.. (2018). Therapeutic Targeting of the DNA Damage Response Using an ATR Inhibitor in Biliary Tract Cancer. Cancer Research and Treatment. 51(3). 1167–1179. 26 indexed citations

11.

Jin, Mei Hua, Ah-Rong Nam, Ji Eun Park, et al.. (2017). Resistance Mechanism against Trastuzumab in HER2-Positive Cancer Cells and Its Negation by Src Inhibition. Molecular Cancer Therapeutics. 16(6). 1145–1154. 47 indexed citations

12.

Nam, Ah-Rong, et al.. (2017). Anti-tumor effects of NVP-BKM120 alone or in combination with MEK162 in biliary tract cancer. Cancer Letters. 411. 162–170. 11 indexed citations

13.

Nam, Ah-Rong, Ji‐Won Kim, Ji Eun Park, et al.. (2016). Src as a Therapeutic Target in Biliary Tract Cancer. Molecular Cancer Therapeutics. 15(7). 1515–1524. 9 indexed citations

14.

Ock, Chan-Young, Ah-Rong Nam, Joongyub Lee, et al.. (2016). Prognostic implication of antitumor immunity measured by the neutrophil–lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer. Gastric Cancer. 20(2). 254–262. 51 indexed citations

15.

Ock, Chan-Young, Ah-Rong Nam, Ju-Hee Bang, et al.. (2015). Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer. Gastric Cancer. 20(1). 164–174. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact